IRIS
PUCCINI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 908
NA - Nord America 907
SA - Sud America 376
EU - Europa 172
AF - Africa 25
Totale 2.388
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 874
SG - Singapore 533
BR - Brasile 308
CN - Cina 161
VN - Vietnam 102
IT - Italia 46
HK - Hong Kong 36
DE - Germania 26
AR - Argentina 22
AT - Austria 18
GB - Regno Unito 18
EC - Ecuador 16
BD - Bangladesh 15
CA - Canada 14
MX - Messico 14
ID - Indonesia 11
IN - India 10
FI - Finlandia 9
FR - Francia 9
CL - Cile 8
RU - Federazione Russa 8
TR - Turchia 8
EG - Egitto 7
ES - Italia 7
JP - Giappone 7
MA - Marocco 7
CO - Colombia 6
UY - Uruguay 6
LT - Lituania 5
NL - Olanda 5
SE - Svezia 5
VE - Venezuela 5
ZA - Sudafrica 5
IQ - Iraq 4
PL - Polonia 4
PY - Paraguay 4
CY - Cipro 3
KE - Kenya 3
SA - Arabia Saudita 3
UA - Ucraina 3
UZ - Uzbekistan 3
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NP - Nepal 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 2.388
Salva come PNG Salva come JPEG
Città #
Dallas 500
Singapore 177
The Dalles 152
Beijing 96
Ashburn 52
Ho Chi Minh City 45
Hong Kong 36
São Paulo 26
Shanghai 21
Hanoi 15
Naples 14
Curitiba 11
Los Angeles 11
Milan 11
Guayaquil 9
Helsinki 9
Mexico City 9
Rio de Janeiro 9
Assago 8
Nuremberg 8
Ankara 7
Brasília 7
New York 7
Porto Alegre 7
Vienna 7
Belo Horizonte 6
London 6
Montreal 6
Can Tho 5
Manaus 5
Montevideo 5
Reston 5
Ribeirão Preto 5
Tokyo 5
Atlanta 4
Biên Hòa 4
Brooklyn 4
Dhaka 4
Haiphong 4
Jakarta 4
Orem 4
Quito 4
Stockholm 4
São José dos Campos 4
Warsaw 4
Betim 3
Camaçari 3
Campinas 3
Chennai 3
Chicago 3
Da Nang 3
Denver 3
Goiânia 3
Hải Dương 3
Joinville 3
Lấp Vò 3
Quận Bình Thạnh 3
Riyadh 3
Roden 3
Seattle 3
Tashkent 3
Turin 3
Antofagasta 2
Baghdad 2
Bogotá 2
Boston 2
Buenos Aires 2
Cairo 2
Camden 2
Campos dos Goytacazes 2
Cape Town 2
Casablanca 2
Cotia 2
Council Bluffs 2
Fortaleza 2
Gaiman 2
Genoa 2
Guarulhos 2
Ha Long 2
Itajaí 2
Itapetininga 2
Jacareí 2
Jaú 2
Johannesburg 2
Luxembourg 2
Macaé 2
Maceió 2
Manchester 2
Mumbai 2
Nairobi 2
Nicosia 2
Nova Iguaçu 2
Piracicaba 2
Poplar 2
Rabat 2
Rockville 2
Salto 2
Salvador 2
San Francisco 2
Santa Clara 2
Totale 1.473
Salva come PNG Salva come JPEG
Nome #
Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life 407
Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study 40
Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting 38
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer 38
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study 38
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 36
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset 35
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors 34
Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 34
Colorectal cancer: epigenetic alterations and their clinical implications 33
Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis 33
Young Patients with Colorectal Cancer: Risk, Screening, and Treatment 33
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials 33
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 32
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 32
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAFV600E-mutated metastatic colorectal cancer treated with targeted therapy 32
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 32
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) 31
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis 31
New perspectives for colorectal cancer 31
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention 30
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study 30
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies 30
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer 30
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3 29
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy 29
Microsatellite-Instability-High Advanced Colorectal Cancer 29
Cisplatin-related Atrial Fibrillation during PEB Chemotherapy for Testicular Seminoma: A Case Report 28
Management of Advanced Small Bowel Cancer 28
A new prognostic and predictive tool for shared decision making in stage III colon cancer 27
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective 26
Redefining Colorectal Cancer by Tumor Biology 26
Tackling hurdles in front of young clinical investigators in oncology – Results from an international survey 26
B cell and B cell-related pathways for novel cancer treatments 26
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM) 26
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting 25
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer 25
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets 24
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care? 24
From walls to wonder: Talking about spaces tailored for adolescents and young adults with cancer 24
Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand? 24
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial 24
The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer 24
Metastatic sarcoma: tailored strategies for a heterogeneous disease 24
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma 23
What We Know About Stage II and III Colon Cancer: It's Still Not Enough 23
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer 23
Maintenance Olaparib for Metastatic Pancreatic Cancer 23
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer 22
A polymorphism within the Vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/ bevacizumab or FOLFIRI/Cetuximab 22
Molecular profile of BRCA-mutated biliary tract cancers 22
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 22
Editorial: New therapeutic approaches in microsatellite stable colorectal cancer patients 22
Outlooks on Epstein-Barr virus associated gastric cancer 22
The role of tumor angiogenesis as a therapeutic target in colorectal cancer 21
Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma 21
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets 21
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3 21
Molecular Variances Between Right- and Left-sided Colon Cancers 20
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy? 20
Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens 20
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center 20
Routinely Updating Patients With Cancer About Variant of Uncertain Significance Reclassifications: A Premature Responsibility for Community Oncologists 20
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study 20
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer 20
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers 19
The impact of ARID1A mutation on molecular characteristics in colorectal cancer 19
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors 19
Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence? 19
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives 18
Practice-changing updates in the adjuvant and metastatic setting 18
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 17
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients 17
The urgent need to improve the tools to assess clinical benefit and value of cancer treatment 16
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions 16
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer 16
Safety and Tolerability of c-MET Inhibitors in Cancer 16
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy 15
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients 15
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers 15
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives 15
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype 15
Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives 14
Reliability of patient-reported toxicities during adjuvant chemotherapy 14
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system 13
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical Trials 9
Fertility Preservation Practices and Gastrointestinal (GI) Oncologist in Europe: A Pan-European study 6
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers 4
Totale 2.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 4 4 4
2024/2025811 1 2 1 4 1 125 80 111 82 182 78 144
2025/20261.661 365 231 552 397 91 25 0 0 0 0 0 0
Totale 2.484